Quantcast

European ADRs Move Lower in Monday Trading


Shutterstock photo

American depositary receipts of European stocks were trading 1.41% lower at 135.34 on the Bank of New York Mellon Europe ADR Index on Monday.

In continental Europe, the gainers were led by biotech firm Zealand Pharma ( ZEAL ), and communications services provider VEON ( VEON ), which rose 4.8% and 2.8% respectively. They were followed by pharmaceutical firm, Sanofi ( SNY ), and healthcare company Novo Nordisk ( NVO ), which were up 1.9% and 1%.

The decliners in continental Europe were led by biotech company ERYTECH Pharma ( ERYP ), and pharmaceutical firm Oasmia Pharmaceutical (OASM), which tumbled 28.7% and 13.4% respectively. They were followed by geophysical equipment maker CGG (CGG), and online dating site operator Spark Networks (LOV), which lost 5.0% and 4.8%.

In the UK and Ireland, the gainers were led by biopharmaceutical firms Akari Therapeutics (AKTX), and Midatech Pharma (MTP), which were up 1.7% and 1.4% respectively. They were followed by gene therapy company Nightstar (NITE), and biotech firm Shire (SHPG), which increased 1.1% and 0.1%.

The decliners in the UK and Ireland were led by cruise line operator Carnival (CUK), and biopharmaceutical firm Verona Pharma (VRNA), which shed 8.7% and 5.4% respectively. They were followed by pharmaceutical firm Avadel (AVDL), and mining company BHP Billiton (BBL), which dropped 4.9% and 3.6%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , Stocks
Referenced Symbols: ZEAL , VEON , SNY , NVO , ERYP


More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities








Research Brokers before you trade

Want to trade FX?